Literature DB >> 35076743

Pantoea dispersa rhinosinusitis: clinical aspects of a rare sinonasal pathogen.

Yi-Wen Su1, Wei-Hao Huang2, Chien-Fu Yeh3,4.   

Abstract

PURPOSE: There is no report in the literature targeting the role of Pantoea dispersa in rhinosinusitis and P. dispersa has not been identified as a commensal bacterium in the sinonasal cavity. We aimed to investigate the role of P. dispersa in rhinosinusitis.
METHODS: We retrospectively reviewed the data of patients diagnosed with rhinosinusitis at a medical center in Taiwan.
RESULTS: A total of 274 rhinosinusitis patients underwent sinus culture between July 2017 and July 2019. All 23 patients with acute P. dispersa rhinosinusitis experienced purulent rhinorrhea; three (13%) had nasal obstruction, but none had olfactory dysfunction, facial pressure/pain and nasal polyp. The patients with P. dispersa received a significantly shorter duration of antibiotic treatment (19.9 ± 2.6 vs. 28.9 ± 2.5 days, P = 0.015) and had lower surgery rate (0% vs. 16.7%, P = 0.043) than other patients. Patients with olfactory dysfunction were more likely to receive surgical treatment (P = 0.018).
CONCLUSION: Acute rhinosinusitis caused by P. dispersa resulted in less surgical interventions and shorter treatment durations. Olfactory dysfunction may imply longer course and possibility for surgical intervention in chronic rhinosinusitis. The present study revealed that P. dispersa had the potential to colonize in human sinonasal cavities and cause rhinosinusitis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Antibiotics; Olfactory dysfunction; Pantoea dispersa; Rhinosinusitis; Surgery

Mesh:

Year:  2022        PMID: 35076743     DOI: 10.1007/s00405-022-07266-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  15 in total

1.  Isolation of a Pantoea dispersa-like strain fron a 71-year-old woman with acute myeloid leukemia and multiple myeloma.

Authors:  H Schmid; S Schubert; C Weber; J R Bogner
Journal:  Infection       Date:  2003-01       Impact factor: 3.553

2.  Assessment of odor identification function in Asia using a modified "Sniffin' Stick" odor identification test.

Authors:  Chih-Hung Shu; Ben-Chih Yuan
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-07       Impact factor: 2.503

3.  Characterization of bacterial community diversity in chronic rhinosinusitis infections using novel culture-independent techniques.

Authors:  Franziska A Stressmann; Geraint B Rogers; Samuel W Chan; Peter H Howarth; Philip G Harries; Ken D Bruce; Rami J Salib
Journal:  Am J Rhinol Allergy       Date:  2011 Jul-Aug       Impact factor: 2.467

4.  Microbiology of the transition from acute to chronic maxillary sinusitis.

Authors:  I Brook; E H Frazier; P A Foote
Journal:  J Med Microbiol       Date:  1996-11       Impact factor: 2.472

5.  EPOS2020: a major step forward.

Authors:  W J Fokkens
Journal:  Rhinology       Date:  2020-02-01       Impact factor: 3.681

Review 6.  Pantoea: insights into a highly versatile and diverse genus within the Enterobacteriaceae.

Authors:  Alyssa M Walterson; John Stavrinides
Journal:  FEMS Microbiol Rev       Date:  2015-06-24       Impact factor: 16.408

Review 7.  Microbiology of chronic rhinosinusitis.

Authors:  I Brook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

8.  Microbiology of sinusitis.

Authors:  Itzhak Brook
Journal:  Proc Am Thorac Soc       Date:  2011-03

9.  Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities.

Authors:  J B Shi; Q L Fu; H Zhang; L Cheng; Y J Wang; D D Zhu; W Lv; S X Liu; P Z Li; C Q Ou; G Xu
Journal:  Allergy       Date:  2015-03-04       Impact factor: 13.146

10.  Pantoea dispersa bacteremia caused by central line-associated bloodstream infection.

Authors:  Hideharu Hagiya; Fumio Otsuka
Journal:  Braz J Infect Dis       Date:  2014-08-29       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.